Cite
HARVARD Citation
Rossing, P. et al. (2022). Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP‐1RA treatment: A subgroup analysis from the FIDELIO‐DKD trial. Diabetes, obesity & metabolism. 24 (1), pp. 125-134. [Online].